Alkem gets 3 USFDA observations after inspection of Ankleshwar unit - Livemint

Livemint
Alkem gets 3 USFDA observations after inspection of Ankleshwar unit
Livemint
In a filing to BSE, Alkem said that it shall put together a detailed response with adequate corrective and preventive measures to address the USFDA observations. New Delhi: Drug firm Alkem Laboratories on Monday said that the US health regulator has ...
Alkem Labs dips on USFDA observations on Ankleshwar API facilityBusiness Standardall 16 news articles »